News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,222 Results
Type
Article (1922)
Company Profile (2)
Press Release (67298)
Section
Business (21464)
Career Advice (9)
Deals (4555)
Drug Development (8159)
FDA (1803)
Job Trends (802)
News (37023)
Policy (3562)
Tag
Academia (92)
Alliances (8115)
Alzheimer's disease (118)
Antibody-drug conjugate (ADC) (7)
Approvals (1815)
Artificial intelligence (8)
Bankruptcy (8)
Best Places to Work (583)
Biosimilars (13)
Breast cancer (13)
Cancer (149)
Career advice (9)
Cell therapy (14)
Clinical research (6926)
Collaboration (58)
COVID-19 (181)
C-suite (7)
Data (134)
Diabetes (10)
Diagnostics (588)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7491)
Events (6879)
Executive appointments (37)
FDA (1892)
Funding (39)
Gene therapy (14)
GLP-1 (39)
Government (233)
Healthcare (1072)
Infectious disease (185)
Inflammatory bowel disease (14)
Intellectual property (7)
IPO (1615)
Job creations (241)
Job search strategy (9)
Layoffs (6)
Legal (945)
Liver cancer (15)
Lung cancer (25)
Lymphoma (8)
Manufacturing (23)
Medical device (1111)
Medtech (1112)
Mergers & acquisitions (3004)
Metabolic disorders (29)
Neuroscience (149)
NextGen: Class of 2025 (221)
Non-profit (64)
Northern California (109)
Obesity (12)
Ovarian cancer (7)
Parkinson's disease (12)
Patents (11)
People (4929)
Phase I (1883)
Phase II (2890)
Phase III (2632)
Pipeline (58)
Postmarket research (241)
Preclinical (651)
Radiopharmaceuticals (22)
Rare diseases (20)
Real estate (598)
Regulatory (2541)
Reports (6)
Research institute (92)
Schizophrenia (6)
Series A (11)
Southern California (98)
Startups (423)
Supply chain (6)
United States (911)
Vaccines (19)
Date
Today (4)
Last 7 days (36)
Last 30 days (157)
Last 365 days (3197)
2025 (119)
2024 (3253)
2023 (3814)
2022 (7013)
2021 (6373)
2020 (5882)
2019 (3867)
2018 (3014)
2017 (3560)
2016 (3172)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Asia (21201)
Australia (2424)
California (239)
Canada (178)
China (117)
Connecticut (11)
Europe (12324)
Florida (14)
Illinois (15)
India (6)
Japan (48)
Maryland (64)
Massachusetts (172)
Minnesota (23)
New Jersey (123)
New York (102)
North Carolina (50)
Northern California (109)
Pennsylvania (33)
South America (105)
Southern California (98)
Texas (15)
Utah (7)
Virginia (13)
69,222 Results for "inflazome ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan
December 25, 2024
·
1 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
December 11, 2024
·
3 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
January 2, 2025
·
2 min read
1 of 6,923
Next
